Multimodal Cancer Therapy Involving Oncolytic Newcastle Disease Virus, Autologous Immune Cells, and Bi-Specific Antibodies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multimodal Cancer Therapy Involving Oncolytic Newcastle Disease Virus, Autologous Immune Cells, and Bi-Specific Antibodies
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-09-11
DOI
10.3389/fonc.2014.00224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
- (2015) Zeshan Niu et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins
- (2014) Volker Schirrmacher et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- (2013) Felix Klug et al. CANCER CELL
- Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
- (2013) P. Bach et al. CANCER RESEARCH
- The Oncolytic Activity of Newcastle Disease Virus in Clear Cell Renal Carcinoma Cells in Normoxic and Hypoxic Conditions: The Interplay Between von Hippel-Lindau and Interferon-β Signaling
- (2013) Wei-Choong Ch'ng et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Prostate-Specific Antigen-Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy
- (2013) R. Shobana et al. JOURNAL OF VIROLOGY
- Expression of interferon gamma by a highly virulent strain of Newcastle disease virus decreases its pathogenicity in chickens
- (2013) Leonardo Susta et al. MICROBIAL PATHOGENESIS
- IL-1 and T Helper Immune Responses
- (2013) Veronica Santarlasci et al. Frontiers in Immunology
- Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
- (2012) Chunchun Meng et al. ARCHIVES OF VIROLOGY
- Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer
- (2012) Philippe Fournier et al. BIODRUGS
- Incorporation of Host Complement Regulatory Proteins into Newcastle Disease Virus Enhances Complement Evasion
- (2012) M. Biswas et al. JOURNAL OF VIROLOGY
- Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo
- (2011) Songshu Meng et al. CANCER LETTERS
- Tumor Antigen-Dependent and Tumor Antigen-Independent Activation of Antitumor Activity in T Cells by a Bispecific Antibody-Modified Tumor Vaccine
- (2011) Philippe Fournier et al. Clinical & Developmental Immunology
- Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies
- (2011) Ilka Knippertz et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
- (2011) Volker Schirrmacher INTERNATIONAL JOURNAL OF ONCOLOGY
- Apoptin Enhances the Oncolytic Properties of Newcastle Disease Virus
- (2011) Yantao Wu et al. INTERVIROLOGY
- Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells
- (2011) M. Mansour et al. JOURNAL OF VIROLOGY
- Use of attenuated paramyxoviruses for cancer therapy
- (2010) Patrycja J Lech et al. Expert Review of Vaccines
- Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
- (2010) Kyo Young Song et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Genetically Engineered Oncolytic Newcastle Disease Virus Effectively Induces Sustained Remission of Malignant Pleural Mesothelioma
- (2010) G. R. Silberhumer et al. MOLECULAR CANCER THERAPEUTICS
- Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
- (2010) J Puhlmann et al. ONCOGENE
- Expression of RIG-I, IRF3, IFN-β and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus
- (2009) Schirrmacher INTERNATIONAL JOURNAL OF ONCOLOGY
- Newcastle Disease Virus Infection Promotes Bax Redistribution to Mitochondria and Cell Death in HeLa Cells
- (2009) Aidin Molouki et al. INTERVIROLOGY
- Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN
- (2009) Z. Xiao et al. JOURNAL OF IMMUNOLOGY
- The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
- (2009) I. Lazar et al. JOURNAL OF VIROLOGY
- Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice
- (2009) Ya-Lin Li et al. LIVER INTERNATIONAL
- Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
- (2009) Dmitriy Zamarin et al. MOLECULAR THERAPY
- Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
- (2009) Jennifer Altomonte et al. MOLECULAR THERAPY
- Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production
- (2009) Hendrik Poeck et al. NATURE IMMUNOLOGY
- Time course of Newcastle disease virus-induced apoptotic pathways
- (2009) P.V. Ravindra et al. VIRUS RESEARCH
- Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
- (2008) T. Schulze et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
- (2008) F Pühler et al. GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now